BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 8567334)

  • 1. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of cesium needle interstitial implantation for carcinoma of the oral tongue.
    Hareyama M; Nishio M; Saito A; Kagami Y; Asano K; Oouchi A; Narimatsu N; Somekawa Y; Sanbe S; Morita K
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):29-34. PubMed ID: 8416878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy.
    Wendt CD; Peters LJ; Delclos L; Ang KK; Morrison WH; Maor MH; Robbins KT; Byers RM; Carlson LS; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1287-92. PubMed ID: 2370178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy for T1 and T2 carcinomas of the tongue: combination therapy using low-dose external irradiation and an interstitial implant].
    Kanehira C; Aoyagi Y; Sugimoto T; Takayama M; Yamanashi S; Watanabe H; Kobori K; Sekine H; Gomi M; Mochizuki S
    Gan No Rinsho; 1988 Oct; 34(12):1642-6. PubMed ID: 3193608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
    Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
    Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques.
    Pernot M; Malissard L; Aletti P; Hoffstetter S; Forçard JJ; Bey P
    Radiother Oncol; 1992 Apr; 23(4):223-8. PubMed ID: 1609126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer.
    Miura M; Takeda M; Sasaki T; Inoue T; Nakayama T; Fukuda H; Hoshi A; Hoshina M; Shibuya H
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):763-70. PubMed ID: 9652836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
    Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
    Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.
    Mazeron JJ; Crook JM; Benck V; Marinello G; Martin M; Raynal M; Haddad E; Peynègre R; Le Bourgeois JP; Walop W
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1369-76. PubMed ID: 2262360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.
    Mazeron JJ; Crook JM; Marinello G; Walop W; Pierquin B
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):281-5. PubMed ID: 2394607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
    Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
    J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
    Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
    Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of surgical margin status and use of an interstitial implant on T1, T2 oral tongue cancers after surgery.
    Chao KS; Emami B; Akhileswaran R; Simpson J; Spector G; Sessions D
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1039-43. PubMed ID: 8985025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
    Lau HY; Hay JH; Flores AD; Threlfall WJ
    Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy (interstitial irradiation) of carcinoma of the tongue--an analysis of cases in the past 10 years].
    Ohyama S; Sato S; Yui N; Iida K; Omura K; Shimada F; Takemia S; Nakano M; Totuka Y; Mizukoshi T
    Gan No Rinsho; 1985 Nov; 31(14):1762-70. PubMed ID: 4087382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 and T2 squamous cell carcinomas of the floor of the mouth: results of brachytherapy mainly using 198Au grains.
    Matsumoto S; Takeda M; Shibuya H; Suzuki S
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):833-41. PubMed ID: 8598360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
    Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.